Progressive improvement after PSE treatment by Dr. Tobinick started 3 years after brain bleed

Treatment by Edward Tobinick M.D., November 4, 2022, at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Rapid relief of 4 years of debilitating stroke pain after treatment by Dr. Tobinick October 2022

Perispinal etanercept treatment by Dr. Tobinick 4 1/2 years after stroke. Immediate and sustained relief of constant, daily, debilitating central post-stroke pain that had lasted more than 4 1/2 years. The central stroke pain had followed a thalamic stroke in 2018, and had been present 24/7 and failed to adequately respond to all previous drug treatment (Thalamic Pain Syndrome). Filmed October 6, 2022, at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

2 patients discuss the amazing change in their chronic stroke pain after treatment by Dr. Tobinick

Filmed October 13, 2022, at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

More improvement immediately after another PSE treatment by Edward Tobinick, M.D.

More improvements in walking and vision immediately after another PSE treatment. Treatment by Dr. Tobinick at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, on November 25, 2020, over 3 years after stroke.

Text, images and video © 2020, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Improvement within minutes following treatment by Edward Tobinick, M.D., 16 months after stroke

Immediate improvement in chronic central post-stroke pain, chronic post-stroke skin hypersensitivity, walking and right hand function following a single dose of perispinal etanercept. Treatment by Dr. Tobinick at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, on November 4, 2020, 16 months after stroke.

Text, images and video © 2020, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Pain improves 7 months after thalamic stroke after treatment by Edward Tobinick, M.D.

Immediate reduction in thalamic pain and related neurological symptoms 7 months after stroke following perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, October 20, 2020.

Text, images and video © 2020, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Thalamic syndrome improves 20 years after stroke following treatment at the INR, Sept. 2018

Improvement in neurological signs and symptoms of thalamic syndrome (Dejerine-Roussy Syndrome) due to a stroke 20 years previously (in 1998) after treatment at the Institute of Neurological Recovery in Boca Raton in September 2018, by Edward Tobinick, M.D. Text, images and video © 2018, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use